Fulminant hepatic failure requiring liver transplantation in 22q13.3 deletion syndrome
暂无分享,去创建一个
T. Haaf | U. Zechner | M. Tufano | R. Weis | R. Iorio | O. Bartsch | E. Schneider | N. Damatova | V. Beyer | A. Ahmed
[1] S. Kaneko,et al. Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver , 2010, Oncogene.
[2] L.-M. Liu,et al. Pim‐3 protects against hepatic failure in D‐galactosamine (D‐GalN)‐sensitized rats , 2010, European journal of clinical investigation.
[3] H. Akkız. Hepatocellular carcinoma pathogenesis: does PPAR alpha polymorphism have a role in hepatocarcinogenesis associated with HBV and HCV infections? , 2008, The Turkish Journal of Gastroenterology.
[4] D. Melis,et al. Fulminant autoimmune hepatitis in a girl with 22q13 deletion syndrome: a previously unreported association , 2008, European Journal of Pediatrics.
[5] J. O'connor,et al. Acute hepatitis and liver failure associated with influenza A infection in children. , 2006, Journal of pediatric gastroenterology and nutrition.
[6] J. Bockmann,et al. Expression of postsynaptic density proteins of the ProSAP/Shank family in the thymus , 2006, Histochemistry and Cell Biology.
[7] P. Wutzler,et al. Fatal outcome of herpes simplex virus type 1-induced necrotic hepatitis in a neonate , 2006, Medical Microbiology and Immunology.
[8] Shuichi Kaneko,et al. Aberrant expression of serine/threonine kinase Pim‐3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines , 2005, International journal of cancer.
[9] Alain Verloes,et al. Specific Genetic Disorders and Autism: Clinical Contribution Towards their Identification , 2005, Journal of autism and developmental disorders.
[10] Jos Jonkers,et al. Mice Deficient for All PIM Kinases Display Reduced Body Size and Impaired Responses to Hematopoietic Growth Factors , 2004, Molecular and Cellular Biology.
[11] J. Graham,et al. 22q13 Deletion Syndrome: An Update and Review for the Primary Pediatrician , 2004, Clinical pediatrics.
[12] L. Vallée,et al. Telomeric 22q13 deletions resulting from rings, simple deletions, and translocations: cytogenetic, molecular, and clinical analyses of 32 new observations , 2003, Journal of medical genetics.
[13] H. McDermid,et al. Molecular characterisation of the 22q13 deletion syndrome supports the role of haploinsufficiency of SHANK3/PROSAP2 in the major neurological symptoms , 2003, Journal of medical genetics.
[14] E. Blennow,et al. FISH-mapping of a 100-kb terminal 22q13 deletion , 2002, Human Genetics.
[15] H. McDermid,et al. 22q13 deletion syndrome. , 2001, American journal of medical genetics.
[16] T. Hudson,et al. Molecular scanning of the human PPARa gene: association of the L162v mutation with hyperapobetalipoproteinemia. , 2000, Journal of lipid research.
[17] M. Manns,et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. , 1999, Journal of hepatology.
[18] J. Saffitz,et al. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice. , 1998, The Journal of clinical investigation.
[19] J. Dumanski,et al. Clinical, cytogenetic, and molecular characterization of seven patients with deletions of chromosome 22q13.3. , 1994, American journal of human genetics.
[20] M. Hirsch,et al. Hepatitis in an adult caused by Herpes simplex virus type I. , 1976, Gastroenterology.
[21] Thomas Bourgeron,et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders , 2007, Nature Genetics.